Radiopharmaceuticals and Associated Consumables
01/05/2019 - 30/04/2022 (option to extend 1x12 months)
This framework provides a one stop solution to assist NHS trusts with their nuclear medicine needs.
If you would like guidance on how to access our frameworks please click here to view our video guide.
Radiopharmaceuticals are a group of pharmaceutical drugs which have radioactivity. Radiopharmaceuticals are used as both diagnostic and therapeutic agents. Radiopharmaceuticals emit radiation themselves, which is different from contrast media which absorb or alter external electromagnetism or ultrasound.
This is a renewal of the previous NOE CPC direct award framework for the provision of radiopharmaceuticals and related consumables; which over its lifetime had delivered a high level of service and supply throughout its duration. The Framework will provide a one stop solution to assist trusts with: -
- Nuclear medicine therapy
- Nuclear medicine diagnostic non-imaging
- Nuclear medicine diagnostic imaging
During the process the sourcing group completely re-evaluated Nuclear Medicine requirements to ensure the framework meets current clinical demands and also supports any future developments in practice. The Sourcing Group consisted of Consultant Medical Physicists, Heads of Nuclear Medicine, Business Managers as well as purchasing professionals whom together have evaluated the specification to ensure that only the highest quality service and supply will be delivered via this framework.
Given the issues surrounding the limited market, escalating costs and the availability of Molybdenum from low enriched uranium sources; The NOE CPC is confident that this framework will give trusts every confidence they need to be able to fulfil the requirements of any Nuclear Medicine Department.
- Cold Kits
- Dry Kits
- Therapy Capsules
- Boston Scientific (formerly Biocompatibles UK Ltd)
- Curium Pharma UK Ltd
- Diagnostic Imaging Ltd
- GE Healthcare Ltd